That's a lot to process, and it makes sense to want to understand what these findings mean for your situation.
Clear cell carcinoma is considered a Type 2 endometrial cancer, which tends to be more aggressive than Type 1. Combined with a grade 3 tumor, this can mean the cancer has a higher chance of spreading or returning Show Full Answer
That's a lot to process, and it makes sense to want to understand what these findings mean for your situation.
Clear cell carcinoma is considered a Type 2 endometrial cancer, which tends to be more aggressive than Type 1. Combined with a grade 3 tumor, this can mean the cancer has a higher chance of spreading or returning. The p53 finding is also significant. A p53 abnormality is a genetic change in the cancer cells that research has linked to poorer outcomes compared to other molecular subtypes. It's one of the factors doctors now use to better understand how a cancer might behave going forward. Given these new findings, it's really important to have a detailed conversation with your cancer care team about whether your current treatment plan needs to be revisited. Some questions worth asking include:
- Does the clear cell finding change my stage or risk category?
- Should additional treatments like chemotherapy or immunotherapy be considered?
- Are there targeted therapies based on my p53 mutation?
- Am I eligible for any clinical trials?
These findings can feel alarming, but knowing about them means your team can make more informed decisions about next steps. You deserve a thorough review of your plan.
June 17
Join
Your Privacy Choices
